Q2 2026 Holdings
Filed 2026-08-14 | 41 holdings | $136.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $10.4M | 410,000 | 7.6% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $9.7M | 1,230,000 | 7.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $8.2M | 143,500 | 6.0% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $7.5M | 22,550 | 5.5% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $6.8M | 205,000 | 5.0% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $6.1M | 164,000 | 4.5% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $5.5M | 51,250 | 4.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $5.4M | 143,500 | 3.9% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $5.0M | 1,025,000 | 3.7% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $4.8M | 82,000 | 3.5% |
| Annexon Inc(ANNX) | COM | 03589W102 | $4.7M | 820,000 | 3.4% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $4.7M | 82,000 | 3.4% |
| Tonix Pharmaceuticals Hldg C(TNXP) | COM NEW | 890260839 | $4.3M | 338,250 | 3.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $4.3M | 57,400 | 3.1% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $4.0M | 16,400 | 2.9% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $3.4M | 205,000 | 2.5% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $3.1M | 1,271,000 | 2.2% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $3.0M | 276,750 | 2.2% |
| DBV Technologies S A(DBVT) | SPONSORED ADS | 23306J309 | $3.0M | 184,500 | 2.2% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $2.8M | 102,500 | 2.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $2.8M | 32,800 | 2.1% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $2.8M | 102,500 | 2.0% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $2.4M | 55,350 | 1.8% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $2.1M | 369,000 | 1.5% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $1.9M | 328,000 | 1.4% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $1.9M | 26,650 | 1.4% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $1.7M | 30,750 | 1.2% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $1.7M | 32,800 | 1.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $1.5M | 5,125 | 1.1% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $1.4M | 41,000 | 1.0% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $1.4M | 123,000 | 1.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $1.3M | 123,000 | 1.0% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $1.3M | 36,900 | 0.9% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $1.2M | 2,460 | 0.9% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $1.1M | 143,490 | 0.8% |
| Monopar Therapeutics Inc(MNPR) | COM NEW | 61023L207 | $1.1M | 12,300 | 0.8% |
| Erasca Inc(ERAS) | COM | 29479A108 | $751.1K | 41,000 | 0.6% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $439.8K | 10,250 | 0.3% |
| Immatics N.v(IMTX) | SHS | N44445109 | $311.5K | 30,750 | 0.2% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $244.2K | 768,750 | 0.2% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $135.0K | 820,000 | 0.1% |